title: [The symptomatic treatment of amyotrophic lateral sclerosis].
abstract: Patients with amyotrophic lateral sclerosis (ALS) have symptoms of progressive muscle weakness, of disturbed speech and swallowing, and in the terminal phase those of respiratory weakness. Treatment options, in particular those for excessive weight loss and respiratory weakness, should be introduced to the patients and their families when the patient is emotionally capable and before dysarthria severely hampers communication. Special equipment for keeping the patient as mobile as possible should be made available much earlier than in the case of other diseases of the muscles as in ALS progression is much faster. Cramps, pathological crying or laughter, spasms, and spasticity can all be treated by medication. When speech can no longer be understood, adaptive strategies such as sign language, mime, posture and communication apparatus varying from a note pad to advanced computer systems can be used. Sialorrhoea, caused by difficulty swallowing with its accompanying danger of aspiration can be halted by the use of medication, by radiotherapy and by the injection into the salivary glands of botulin A toxin. Weight loss, also a result of dysphagia, can be avoided by eating frequent small meals or if necessary performing a percutaneous endoscopic or radiological gastroscopy. Excess mucus in the respiratory tract can be treated with anticholinergics. Difficulty in coughing up thick and sticky mucus cannot always be adequately helped. Respiratory weakness is treatable by external respiratory supportive therapy using a nasal mask, as well as invasive respiratory support via a trachcostoma and by treating the symptoms of respiratory weakness. The latter form of treatment is palliative and forms part of terminal care. During the terminal phase restlessness, anxiety, pain, and dyspnoea require the most attention. Treatment requires careful multidisciplinary cooperation.
authors.affiliation: Afd. Neurologie, Universitair Medisch Centrum Utrecht, Utrecht.
authors.forename: L H
authors.initials: LH
authors.lastname: van den Berg
authors.forename: J P
authors.initials: JP
authors.lastname: van den Berg
authors.forename: E M
authors.initials: EM
authors.lastname: Mathus-Vliegen
authors.forename: M J
authors.initials: MJ
authors.lastname: Kampelmacher
authors.forename: R G
authors.initials: RG
authors.lastname: van Kesteren
authors.forename: F G
authors.initials: FG
authors.lastname: Jennekens
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000628:therapy*; D003680:Deglutition Disorders / Q000209:etiology / Q000517:prevention & control; D004401:Dysarthria / Q000209:etiology / Q000517:prevention & control; D004417:Dyspnea / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D018908:Muscle Weakness / Q000209:etiology / Q000517:prevention & control; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D010166:Palliative Care; D012798:Sialorrhea / Q000209:etiology / Q000517:prevention & control; D015431:Weight Loss